Angiotensin converting enzyme-2 as therapeutic target in COVID-19
Author:
Publisher
Elsevier BV
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference36 articles.
1. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during covid-19 pandemic;Cure;Diabetes Metabol Syndr: Clin Res Rev,2020
2. Oleoylethanolamide, a bioactive lipid amide, as a promising treatment strategy for coronavirus/covid-19;Ghaffari;Arch Med Res,2020
3. The cardiovascular burden of coronavirus disease 2019 (covid-19) with a focus on congenital heart disease;Tan;Int J Cardiol,2020
4. A genomic perspective on the origin and emergence of sars-cov-2;Zhang;Cell,2020
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Renal Autoimmunity: The Role of Bacterial and Viral Infections – An Extensive Review;Infection and Autoimmunity;2024
2. Enhanced binding and inhibition of SARS‐CoV‐2 by a plant‐derived ACE2 protein containing a fused mu tailpiece;Biotechnology Journal;2023-11-05
3. Neutralization of the new coronavirus by extracting their spikes using engineered liposomes;Nanomedicine: Nanotechnology, Biology and Medicine;2023-06
4. Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence;Viruses;2023-05-27
5. In-silico Studies of Active Phytochemicals from Siddha Medicinal Herbs of Karisalai Chooranam against SARS-CoV-2 main Protease (3CLpro), RNA Dependent RNA Polymerase and Angiotensin-Converting Enzyme II Receptor;Research Journal of Pharmacy and Technology;2023-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3